Real-world treatment patterns and outcomes in ER+/PR+/HER2+metastatic breast cancer (MBC) patients: A National Cancer Database analysis.

被引:2
|
作者
Statler, Abby
Nahleh, Zeina A.
Hobbs, Brian
Wei, Wei
Gupta, Annie
Blake, Cassann N.
机构
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin Florida, El Paso, TX USA
[3] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA
[4] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[5] Cleveland Clin Florida, Weston, FL USA
关键词
D O I
10.1200/JCO.2019.37.15_suppl.1033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1033
引用
下载
收藏
页数:2
相关论文
共 50 条
  • [31] Treatment Patterns and Outcomes of Patients With Metastatic ER+/HER-2- Breast Cancer: A Multicountry Retrospective Medical Record Review
    Kurosky, Samantha K.
    Mitra, Debanali
    Zanotti, Giovanni
    Kaye, James A.
    CLINICAL BREAST CANCER, 2018, 18 (04) : E529 - E538
  • [32] Real-world aromatase inhibitor use and failure in women with metastatic ER+/HER2-breast cancer.
    Landsman-Blumberg, Pamela
    Namjoshi, Madhav
    Thomson, Erin
    Johnson, William
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Treatment and outcomes of older versus younger women with HER2 positive metastatic breast cancer in the real-world national ESME database
    Annonay, Mylene
    Gauquelin, Lisa
    Geiss, Romain
    Ung, Mony
    Cristol-Dalstein, Laurence
    Mouret-Reynier, Marie-Ange
    Goncalves, Anthony
    Abadie-Lacourtoisie, Sophie
    Francois, Eric
    Perrin, Christophe
    Le Fel, Johan
    Lorgis, Veronique
    Servent, Veronique
    Uwer, Lionel
    Jouannaud, Christelle
    Leheurteur, Marianne
    Joly, Florence
    Campion, Loic
    Courtinard, Coralie
    Villacroux, Olivier
    Petit, Thierry
    Soubeyran, Pierre
    Terret, Catherine
    Bellera, Carine
    Brain, Etienne
    Delaloge, Suzette
    BREAST, 2021, 60 : 138 - 146
  • [34] Using real-world data to evaluate the performance of endocrine therapies in ER+/Her2-metastatic breast cancer patients.
    Chen, Tenghui
    Zhang, Zhaojie
    Gao, Lei
    Scholz, Catherine
    Gualberto, Antonio
    Yu, Lihua
    Yu, Kun
    CANCER RESEARCH, 2022, 82 (12)
  • [35] A non-interventional study to characterize the real world treatment patterns and outcomes of women with ER+, HER2-advanced or metastatic breast cancer in Italy
    De Laurentiis, M.
    Mitra, D.
    Bell, T.
    Nuzzo, C. M. A.
    De Placido, S.
    CANCER RESEARCH, 2016, 76
  • [36] Predictors of survival in patients with HER2+metastatic breast cancer (MBC) treated with trastuzumab
    Olson, E. M.
    Najita, J. S.
    Sohl, J.
    Arnaout, A.
    Winer, E. P.
    Lin, N. U.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Real-world characteristics, treatment patterns, and overall survival in patients with metastatic breast cancer (mBC) and CNS metastases
    Alvarado-Miranda, A.
    Cabrera-Galeana, P.
    Munoz-Montano, W. R.
    Lara-Medina, F.
    Bargallo-Rocha, E.
    Arrieta-Rodriguez, O.
    Perez, M.
    Porras-Reyes, F.
    Mohar-Betancourt, A.
    Gamboa, C.
    CANCER RESEARCH, 2019, 79 (04)
  • [38] The mutational profile of ER-, PR+, HER2-metastatic breast cancer.
    Fischbach, Neal A.
    Huang, Richard S. P.
    Lustberg, Maryam B.
    Pelletier, Maureen
    Pusztai, Lajos
    Sivakumar, Smruthy
    Sokol, Ethan
    Ross, Jeffrey S.
    Levy, Mia Alyce
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] PRELIMINARY DATA FROM A PROSPECTIVE NON-INTERVENTIONAL STUDY TO CHARACTERIZE REAL-WORLD TREATMENT PATTERNS AND OUTCOMES OF WOMEN WITH ER+/HER2-ADVANCED/METASTATIC BREAST CANCER
    Cazzaniga, Marina Elena
    Cagossi, Katia
    Valerio, Maria Rosaria
    Russo, Salvatore
    Casadei, Virginia
    Scognamiglio, Giovanni
    Cavanna, Luigi
    Toniolo, Davide
    Deconciliis, Erico Maria Romani
    Melegari, Elisabetta
    Stocchi, Lucia
    Gebbia, Vittorio
    Vandone, Anna Maria
    Cursano, Maria Concetta
    Pinotti, Graziella
    Rossello, Rosalba
    Ortu, Salvatorico
    Pellegrino, Benedetta
    Saracchini, Silvana
    Pedroli, Stefania
    Torri, Valter
    BREAST, 2017, 36 : S48 - S49
  • [40] Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis
    Patt, Debra
    Liu, Xianchen
    Li, Benjamin
    McRoy, Lynn
    Layman, Rachel M.
    Brufsky, Adam
    CLINICAL BREAST CANCER, 2022, 22 (06) : 601 - 610